MedTrace Logo

S-adenosylmethionine Plus Choline in Treatment of Patients With Alcoholic Liver Disease

NCT03938662 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2019-05-29

No results posted yet for this study

Summary

The study will assess the effect of treatment with formulation containing S-Adenosyl methionine and choline, on patients with alcoholic liver disease.

Half of the patients included will receive named formulation once daily for 24 weeks while other half will receive placebo.

Conditions

  • Alcoholic Liver Diseases

Interventions

DIETARY_SUPPLEMENT

formulation containing S-Adenosyl methionine and choline

Patients will be administered with formulation containing S-Adenosyl methionine and choline once daily for the period of 24 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo of same appearance, colour and taste,

Sponsors & Collaborators

  • University Clinic Dr Dragisa Misovic-Dedinje

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-09
Primary Completion
2020-04-01
Completion
2020-04-01

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938662 on ClinicalTrials.gov